ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019
Erytech Pharma S.A. - American Depositary Shares (ERYP)
US:NASDAQ Investor Relations:
investors.erytech.com
Company Research
Source: GlobeNewswire
More than two-thirds of the expected number of patients have been enrolled in the TRYbeCA-1 Phase 3 clinical trialCash position of €73.2 million ($82.2 million) at the end of 2019 LYON, France and CAMBRIDGE, Mass., March 16, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today provided a business update and reported its financial results for the fourth quarter and year ended December 31, 2019. “2019 has been a year of tremendous execution towards realizing our vision of helping cancer patients to live longer and better,” said Gil Beyen, CEO of ERYTECH. “Not only did we fully operationalize a large Phase 3 trial of eryaspase in 11 European countries and the United States, we also launched a Phase 2 clinical trial of eryaspase in a new indication, triple-negative breast cancer, and supported two investigator-sponsored
Show less
Read more
Impact Snapshot
Event Time:
ERYP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ERYP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ERYP alerts
High impacting Erytech Pharma S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics